645 related articles for article (PubMed ID: 19208560)
1. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560
[TBL] [Abstract][Full Text] [Related]
2. [Recurrent spontaneous abortion--is heparin expendable to recurrence prophylaxis?].
Krüger K
Z Rheumatol; 2009 Aug; 68(6):510-1. PubMed ID: 19575211
[No Abstract] [Full Text] [Related]
3. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
Areia AL; Fonseca E; Areia M; Moura P
Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
[TBL] [Abstract][Full Text] [Related]
4. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
de Jong PG; Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD004734. PubMed ID: 24995856
[TBL] [Abstract][Full Text] [Related]
5. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis on aspirin combined with low-molecular-weight heparin for improving the live birth rate in patients with antiphospholipid syndrome and its correlation with d-dimer levels.
Shi T; Gu ZD; Diao QZ
Medicine (Baltimore); 2021 Jun; 100(25):e26264. PubMed ID: 34160390
[TBL] [Abstract][Full Text] [Related]
7. Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation.
Karadağ C; Akar B; Gönenç G; Aslancan R; Yılmaz N; Çalışkan E
J Matern Fetal Neonatal Med; 2020 Jun; 33(11):1934-1939. PubMed ID: 31550962
[No Abstract] [Full Text] [Related]
8. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
[TBL] [Abstract][Full Text] [Related]
9. Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.
Mutlu I; Mutlu MF; Biri A; Bulut B; Erdem M; Erdem A
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):267-73. PubMed ID: 25268607
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of threatened abortions after anticoagulation treatment to prevent recurrent pregnancy loss.
Rottenstreich A; Amsalem H; Kleinstern G; Kalish Y
Reprod Biomed Online; 2017 Oct; 35(4):461-467. PubMed ID: 28756129
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic therapy for pregnancy loss.
de Jong PG; Goddijn M; Middeldorp S
Hum Reprod Update; 2013; 19(6):656-73. PubMed ID: 23766357
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome.
Di Nisio M; Peters L; Middeldorp S
Cochrane Database Syst Rev; 2005 Apr; (2):CD004734. PubMed ID: 15846729
[TBL] [Abstract][Full Text] [Related]
13. Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome.
Alalaf S
Arch Gynecol Obstet; 2012 Mar; 285(3):641-7. PubMed ID: 21842174
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
Noble LS; Kutteh WH; Lashey N; Franklin RD; Herrada J
Fertil Steril; 2005 Mar; 83(3):684-90. PubMed ID: 15749498
[TBL] [Abstract][Full Text] [Related]
15. Hold your needles in women with recurrent pregnancy losses with or without hereditary thrombophilia: Meta-analysis and review of the literature.
Intzes S; Symeonidou M; Zagoridis K; Stamou M; Spanoudaki A; Spanoudakis E
J Gynecol Obstet Hum Reprod; 2021 Apr; 50(4):101935. PubMed ID: 33035720
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss.
Giancotti A; La Torre R; Spagnuolo A; D'Ambrosio V; Cerekja A; Piazze J; Chistolini A
J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1191-4. PubMed ID: 21988715
[TBL] [Abstract][Full Text] [Related]
17. D-Dimer Assay May Guide LMWH Treatment in Repeated Biochemical Pregnancy Losses in Women with Positive Antiphospholipid Antibody.
Bao SH; Frempong ST; Ruan JL
Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162875
[TBL] [Abstract][Full Text] [Related]
18. Thromboprophylaxis implementation during pregnancy in women with recurrent foetal losses and thrombophilia.
Mitić G; Novakov Mikić A; Povazan L; Mitreski A; Kopitović V; Vejnović T
Med Pregl; 2011; 64(9-10):471-5. PubMed ID: 22097113
[TBL] [Abstract][Full Text] [Related]
19. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.
Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G
Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426
[TBL] [Abstract][Full Text] [Related]
20. Findings from a multicentre, observational study on reproductive outcomes in women with unexplained recurrent pregnancy loss: the OTTILIA registry.
Grandone E; Tiscia GL; Mastroianno M; Larciprete G; Kovac M; Tamborini Permunian E; Lojacono A; Barcellona D; Bitsadze V; Khizroeva J; Makatsarya A; Cacciola R; Martinelli I; Bucherini E; De Stefano V; Lodigiani C; Colaizzo D; De Laurenzo A; Piazza G; Margaglione M
Hum Reprod; 2021 Jul; 36(8):2083-2090. PubMed ID: 34195794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
